Abbas Ardehali
Director/Board Member presso BIOM'UP
Profilo
Abbas Ardehali is currently a Director at Biom'Up SA and Medcura, Inc. He received a doctorate degree from Emory University School of Medicine in 1986.
Posizioni attive di Abbas Ardehali
Società | Posizione | Inizio |
---|---|---|
BIOM'UP | Director/Board Member | 30/01/2018 |
Medcura, Inc.
Medcura, Inc. Medical SpecialtiesHealth Technology Medcura, Inc. develops novel line of hemostatic and wound treatment products. The firm?s products include vascular gel-e, nuisance bleed, chronic wound, and surgical gel-e. The company was founded by Matthew Dowling in January 2013 and is headquartered in Riverdale, MD. | Director/Board Member | 01/06/2023 |
Formazione di Abbas Ardehali
Emory University School of Medicine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
Biom'Up SA
Biom'Up SA Medical SpecialtiesHealth Technology Biom'Up SA engages in the development of hemostatic product composed of patent-protected biopolymers. Its products include Hemoblast Bellows and Hemosnow. The company was founded by Patricia Forest, Sylvain Picot and Christian Gagnieu on February 21, 2005 and is headquartered in Lyon, France. | Health Technology |
Medcura, Inc.
Medcura, Inc. Medical SpecialtiesHealth Technology Medcura, Inc. develops novel line of hemostatic and wound treatment products. The firm?s products include vascular gel-e, nuisance bleed, chronic wound, and surgical gel-e. The company was founded by Matthew Dowling in January 2013 and is headquartered in Riverdale, MD. | Health Technology |
- Borsa valori
- Insiders
- Abbas Ardehali